CHART INDUSTRIES INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that CHART INDUSTRIES INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $988.80M | Feb 22, 2018 |
| FY2017 | Dec 31, 2016 | $859.20M | Feb 22, 2018 |
| FY2017 | Dec 31, 2015 | $1.04B | Feb 22, 2018 |
| FY2016 | Dec 31, 2014 | $1.19B | Feb 23, 2017 |
| FY2015 | Dec 31, 2013 | $1.18B | Feb 26, 2016 |
| FY2014 | Dec 31, 2012 | $1.01B | Feb 24, 2015 |
| FY2013 | Dec 31, 2011 | $794.59M | Feb 25, 2014 |
| FY2012 | Dec 31, 2010 | $555.46M | Feb 28, 2013 |
| FY2011 | Dec 31, 2009 | $597.46M | Mar 29, 2012 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.26B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $4.16B | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $3.35B | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $1.61B | Feb 28, 2025 |
| FY2021 | Dec 31, 2021 | $378.90M | Feb 24, 2022 |
| FY2021 | Sep 30, 2021 | $328.30M | Feb 24, 2022 |
| FY2021 | Jun 30, 2021 | $322.00M | Feb 24, 2022 |
| FY2021 | Mar 31, 2021 | $288.50M | Feb 24, 2022 |
| FY2021 | Dec 31, 2020 | $312.40M | Feb 24, 2022 |
| FY2021 | Sep 30, 2020 | $273.20M | Feb 24, 2022 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $306.00M | Feb 22, 2018 |
| FY2017 | Sep 30, 2017 | $240.50M | Feb 22, 2018 |
| FY2017 | Jun 30, 2017 | $238.20M | Feb 22, 2018 |
| FY2017 | Mar 31, 2017 | $204.10M | Feb 22, 2018 |
| FY2017 | Dec 31, 2016 | $214.40M | Feb 22, 2018 |
| FY2017 | Sep 30, 2016 | $203.90M | Feb 22, 2018 |
| FY2017 | Jun 30, 2016 | $247.10M | Feb 22, 2018 |
| FY2017 | Mar 31, 2016 | $193.80M | Feb 22, 2018 |
| FY2016 | Dec 31, 2015 | $260.76M | Feb 23, 2017 |
| FY2016 | Sep 30, 2015 | $264.05M | Feb 23, 2017 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.44B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $1.39B | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $1.04B | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $407.40M | Feb 28, 2025 |
| FY2021 | Dec 31, 2021 | $82.20M | Feb 24, 2022 |
| FY2021 | Sep 30, 2021 | $74.90M | Feb 24, 2022 |
| FY2021 | Jun 30, 2021 | $83.20M | Feb 24, 2022 |
| FY2021 | Mar 31, 2021 | $83.90M | Feb 24, 2022 |
| FY2021 | Dec 31, 2020 | $87.90M | Feb 24, 2022 |
| FY2021 | Sep 30, 2020 | $78.60M | Feb 24, 2022 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $40.70M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $218.50M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $47.30M | Feb 27, 2026 |
| FY2025 | Dec 31, 2022 | $24.00M | Feb 27, 2026 |
| FY2021 | Dec 31, 2021 | $12.10M | Feb 24, 2022 |
| FY2021 | Sep 30, 2021 | $14.90M | Feb 24, 2022 |
| FY2021 | Jun 30, 2021 | $6.50M | Feb 24, 2022 |
| FY2021 | Mar 31, 2021 | $25.60M | Feb 24, 2022 |
| FY2021 | Dec 31, 2020 | $257.80M | Feb 24, 2022 |
| FY2021 | Sep 30, 2020 | $21.70M | Feb 24, 2022 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $358.40M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $647.50M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $390.70M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $151.50M | Feb 28, 2025 |
| FY2021 | Dec 31, 2021 | $20.40M | Feb 24, 2022 |
| FY2021 | Sep 30, 2021 | $13.80M | Feb 24, 2022 |
| FY2021 | Jun 30, 2021 | $25.50M | Feb 24, 2022 |
| FY2021 | Mar 31, 2021 | $28.80M | Feb 24, 2022 |
| FY2021 | Dec 31, 2020 | $22.50M | Feb 24, 2022 |
| FY2021 | Sep 30, 2020 | $28.10M | Feb 24, 2022 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $41.90M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $38.30M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $23.30M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $13.50M | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $12.70M | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $9.10M | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $9.20M | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $8.70M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $7.10M | Feb 14, 2020 |
| FY2018 | Dec 31, 2016 | $7.60M | Feb 22, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $619.10M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $547.40M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $486.30M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $214.50M | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $196.80M | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $178.20M | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $205.70M | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $172.70M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $180.90M | Feb 14, 2020 |
| FY2018 | Dec 31, 2016 | $158.70M | Feb 22, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $292.70M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $503.00M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $167.20M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $80.80M | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | ($21.30M) | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $172.70M | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $133.90M | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $88.80M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $44.30M | Feb 14, 2020 |
| FY2018 | Dec 31, 2016 | $169.30M | Feb 22, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $89.90M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $120.80M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $135.60M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $74.20M | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $52.70M | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $37.90M | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $36.20M | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $36.40M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $33.00M | Feb 14, 2020 |
| FY2018 | Dec 31, 2016 | $16.70M | Feb 22, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.81B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $9.12B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $9.10B | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $5.90B | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $3.04B | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $2.57B | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $2.48B | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $1.90B | Feb 14, 2020 |
| FY2018 | Dec 31, 2017 | $1.72B | Feb 22, 2019 |
| FY2017 | Dec 31, 2016 | $1.23B | Feb 22, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.43B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $6.13B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $6.16B | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $3.22B | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $1.42B | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $991.20M | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $1.25B | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $1.01B | Feb 14, 2020 |
| FY2018 | Dec 31, 2017 | $919.50M | Feb 22, 2019 |
| FY2017 | Dec 31, 2016 | $534.40M | Feb 22, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.23B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $2.83B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $2.79B | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $2.68B | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $1.62B | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $1.57B | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $1.23B | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $884.50M | Feb 14, 2020 |
| FY2018 | Dec 31, 2017 | $802.20M | Feb 22, 2019 |
| FY2017 | Dec 31, 2016 | $697.20M | Feb 22, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.07B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $2.90B | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $2.91B | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $992.00M | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $994.60M | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $865.90M | Feb 24, 2023 |
| FY2021 | Oct 1, 2020 | $817.60M | Feb 24, 2022 |
| FY2021 | Sep 30, 2020 | $817.60M | Feb 24, 2022 |
| FY2021 | Dec 31, 2019 | $811.40M | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $487.20M | Mar 1, 2021 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.13B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $1.11B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $922.10M | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $902.20M | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $878.20M | Feb 24, 2023 |
| FY2022 | Dec 31, 2020 | $808.40M | Feb 24, 2023 |
| FY2020 | Dec 31, 2019 | $500.30M | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $453.90M | Feb 14, 2020 |
| FY2018 | Dec 31, 2017 | $364.30M | Feb 22, 2019 |
| FY2017 | Dec 31, 2016 | $336.30M | Feb 22, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $366.00M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $308.60M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $188.30M | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $663.60M | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $122.20M | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $125.10M | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $119.00M | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $118.10M | Feb 14, 2020 |
| FY2018 | Dec 31, 2017 | $122.60M | Feb 22, 2019 |
| FY2017 | Dec 31, 2016 | $282.00M | Feb 22, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.66B | Feb 27, 2026 |
| FY2024 | Dec 31, 2024 | $3.76B | Feb 28, 2025 |
| FY2023 | Dec 31, 2023 | $3.96B | Feb 28, 2024 |
| FY2022 | Dec 31, 2022 | $2.33B | Feb 24, 2023 |
| FY2021 | Dec 31, 2021 | $859.60M | Feb 24, 2022 |
| FY2019 | Dec 31, 2019 | $829.40M | Feb 14, 2020 |
| FY2018 | Dec 31, 2018 | $599.30M | Feb 22, 2019 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 4 | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 28, 2025 |
| FY2021 | Dec 31, 2021 | 0 | Feb 24, 2022 |
| FY2021 | Sep 30, 2021 | 0 | Feb 24, 2022 |
| FY2021 | Jun 30, 2021 | 0 | Feb 24, 2022 |
| FY2021 | Mar 31, 2021 | 0 | Feb 24, 2022 |
| FY2021 | Dec 31, 2020 | 7 | Feb 24, 2022 |
| FY2021 | Sep 30, 2020 | 0 | Feb 24, 2022 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 4 | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 28, 2025 |
| FY2021 | Dec 31, 2021 | 0 | Feb 24, 2022 |
| FY2021 | Sep 30, 2021 | 0 | Feb 24, 2022 |
| FY2021 | Jun 30, 2021 | 0 | Feb 24, 2022 |
| FY2021 | Mar 31, 2021 | 0 | Feb 24, 2022 |
| FY2021 | Dec 31, 2020 | 6 | Feb 24, 2022 |
| FY2021 | Sep 30, 2020 | 0 | Feb 24, 2022 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | 42.75M | Feb 28, 2024 |
| FY2023 | Dec 31, 2022 | 42.56M | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | 36.55M | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | 36.19M | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | 35.80M | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | 31.36M | Feb 14, 2020 |
| FY2018 | Dec 31, 2017 | 30.80M | Feb 22, 2019 |
| FY2017 | Dec 31, 2016 | 30.61M | Feb 22, 2018 |
| FY2016 | Dec 31, 2015 | 30.55M | Feb 23, 2017 |
| FY2015 | Dec 31, 2014 | 30.48M | Feb 26, 2016 |